NEWS
SUBSCRIBER SEARCH (Requires Login)
  NEW DRUGS
  MARKETED DRUGS
  COMPANY
  TARGETS IN ONCOLOGY
  NEWS SUMMARIES
  COMBINATION TRIALS

Latest Updates

First Quarter 2012 Targets in Oncology Updates and Additions

  • Annexin A10 (ANXA10)
  • Aurora B
  • Cyclin
  • Ephrin-A1 (EFNA1)
  • Heat shock 70kDa protein 5 (HSPA5)
  • Isocitrate dehydrogenase 1 (IDH1)
  • Let-7 microRNA (miRNA)
  • MUC16
  • Nestin (NES)
  • Phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA)
  • Phosphoinositide-3-kinase, catalytic, delta polypeptide (PIK3CD)
  • Serine/threonine kinase 11 (STK11)
  •   

    Home   |    Freelance Opportunities   |   New Medicine   |   Site Map   |  Order/Inquiry   
    SUBSCRIBER SEARCH:   NEW DRUG   |   MARKETED DRUG   |   COMPANY   |   TARGETS IN ONCOLOGY  

    NEW MEDICINE, INC.
    P.O. BOX 909, LAKE FOREST, CA 92609
    PHONE:  1-949-830-0448     FAX:  1-949-830-0887
    INFO@NEWMEDINC.COM